There is
overwhelming evidence that links maternal nutrition during pregnancy with fetal
outcomes. This study evaluated the safety and efficacy of
Protiva treatment responses in pre and postpartum female subjects
between the ages of 19 years and 43 years who entered into this open label
study.
The protocol was
designed to take a twice daily collagen protein supplementation drink during
the third trimester and for 10 weeks postpartum.
The outcomes were
measured against a control group of patients who did not take the protein
supplementation. The differences between mean score for the physical health
domain of WHOQOL-BREF scale in the Protiva group and the control group were
different and met statistical significance (p=0.0003).
No comments:
Post a Comment